TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 1, 2021 /PRNewswire/ — Memic, a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization of its Hominis® robot-assisted surgical platform for use in single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures including benign hysterectomy.

Read more here.